P4738New combined risk score to predict atrial fibrillation after cardiac surgery
Abstract Introduction Atrial fibrillation after cardiac surgery (AFCS) is associated with an increase in adverse events. The scores POAF, CHA2DS2-VASc and HATCH demonstrated a validated predictive to predict AF after CS (AFCS). Purpose To develop and validate a new risk score from the combination of...
Saved in:
Published in | European heart journal Vol. 40; no. Supplement_1 |
---|---|
Main Authors | , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Oxford University Press
01.10.2019
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Abstract
Introduction
Atrial fibrillation after cardiac surgery (AFCS) is associated with an increase in adverse events. The scores POAF, CHA2DS2-VASc and HATCH demonstrated a validated predictive to predict AF after CS (AFCS).
Purpose
To develop and validate a new risk score from the combination of the variables with highest predictive value of POAF, CHA2DS2-VASc and HATCH risk scores to predict AFCS.
Methodology
We conducted a single-center cohort study, performing a retrospective analysis of prospectively collected data. The study included consecutive patients undergoing CS between 2010–2016. The primary outcome was the development of new-onset AFCS during hospitalization. The variables of each score were evaluated in a multivariate regression model to determine the predictive impact. Discrimination was evaluated with area under the ROC curve (AUC-ROC) and calibration using the Hosmer-Lemeshow (HL) test. The Youden index was used to establish the best cut-off point for the score. The statistical difference between the ROC curves was evaluated with the method of DeLong et al.
Results
3113 patients were included. Coronary artery bypass graft surgery 45%, valve replacement 24%, combined procedure (revascularization-valve surgery) 15%, and other procedures 16%. 21% (n=654) presented AFCS. Variables finally included in the new score were: age (≥75: 2, 65–74: 1), heart failure (2), female sex (1), hypertension (1), diabetes (1), previous stroke (1). The new score presented an AUC of 0.78 (95% CI 0.78–0.80), the rest of the scores presented lower discrimination ability (P<0.001): CHAD2DS2-VASc AUC 0.76, POAF 0.71 and HATCH 0.70. The HL test showed a p>0.05. For the new score, the best cut-off point was 2, with a sensitivity of 82% and specificity of 65.9%, presenting high negative predictive value: 92.9%.
Variables
OR (CI 95%)
P
Age (years)
65–74
3.14 (2.29–4.31)
<0.001
≥75
8.68 (6.32–11.93)
<0.001
Female sex
3.36 (2.68–4.22)
<0.001
Heart failure
2.45 (1.82–3.31)
<0.001
Stroke/TIA
2.33 (1.45–3.76)
<0.001
Hypertension
1.68 (1.28–2.2)
<0.001
Diabetes
1.72 (1.31–2.25)
<0.001
Conclusion
From the combination of variables with higher predictive value included in the POAF, CHA2DS2-VASc, and HATCH scores, a new risk system was created to predict AFCS, presenting a greater predictive ability than the original ones. Being necessary future prospective validations. |
---|---|
AbstractList | Abstract
Introduction
Atrial fibrillation after cardiac surgery (AFCS) is associated with an increase in adverse events. The scores POAF, CHA2DS2-VASc and HATCH demonstrated a validated predictive to predict AF after CS (AFCS).
Purpose
To develop and validate a new risk score from the combination of the variables with highest predictive value of POAF, CHA2DS2-VASc and HATCH risk scores to predict AFCS.
Methodology
We conducted a single-center cohort study, performing a retrospective analysis of prospectively collected data. The study included consecutive patients undergoing CS between 2010–2016. The primary outcome was the development of new-onset AFCS during hospitalization. The variables of each score were evaluated in a multivariate regression model to determine the predictive impact. Discrimination was evaluated with area under the ROC curve (AUC-ROC) and calibration using the Hosmer-Lemeshow (HL) test. The Youden index was used to establish the best cut-off point for the score. The statistical difference between the ROC curves was evaluated with the method of DeLong et al.
Results
3113 patients were included. Coronary artery bypass graft surgery 45%, valve replacement 24%, combined procedure (revascularization-valve surgery) 15%, and other procedures 16%. 21% (n=654) presented AFCS. Variables finally included in the new score were: age (≥75: 2, 65–74: 1), heart failure (2), female sex (1), hypertension (1), diabetes (1), previous stroke (1). The new score presented an AUC of 0.78 (95% CI 0.78–0.80), the rest of the scores presented lower discrimination ability (P<0.001): CHAD2DS2-VASc AUC 0.76, POAF 0.71 and HATCH 0.70. The HL test showed a p>0.05. For the new score, the best cut-off point was 2, with a sensitivity of 82% and specificity of 65.9%, presenting high negative predictive value: 92.9%.
Variables OR (CI 95%) P Age (years) 65–74 3.14 (2.29–4.31) <0.001 ≥75 8.68 (6.32–11.93) <0.001 Female sex 3.36 (2.68–4.22) <0.001 Heart failure 2.45 (1.82–3.31) <0.001 Stroke/TIA 2.33 (1.45–3.76) <0.001 Hypertension 1.68 (1.28–2.2) <0.001 Diabetes 1.72 (1.31–2.25) <0.001
Conclusion
From the combination of variables with higher predictive value included in the POAF, CHA2DS2-VASc, and HATCH scores, a new risk system was created to predict AFCS, presenting a greater predictive ability than the original ones. Being necessary future prospective validations. Abstract Introduction Atrial fibrillation after cardiac surgery (AFCS) is associated with an increase in adverse events. The scores POAF, CHA2DS2-VASc and HATCH demonstrated a validated predictive to predict AF after CS (AFCS). Purpose To develop and validate a new risk score from the combination of the variables with highest predictive value of POAF, CHA2DS2-VASc and HATCH risk scores to predict AFCS. Methodology We conducted a single-center cohort study, performing a retrospective analysis of prospectively collected data. The study included consecutive patients undergoing CS between 2010–2016. The primary outcome was the development of new-onset AFCS during hospitalization. The variables of each score were evaluated in a multivariate regression model to determine the predictive impact. Discrimination was evaluated with area under the ROC curve (AUC-ROC) and calibration using the Hosmer-Lemeshow (HL) test. The Youden index was used to establish the best cut-off point for the score. The statistical difference between the ROC curves was evaluated with the method of DeLong et al. Results 3113 patients were included. Coronary artery bypass graft surgery 45%, valve replacement 24%, combined procedure (revascularization-valve surgery) 15%, and other procedures 16%. 21% (n=654) presented AFCS. Variables finally included in the new score were: age (≥75: 2, 65–74: 1), heart failure (2), female sex (1), hypertension (1), diabetes (1), previous stroke (1). The new score presented an AUC of 0.78 (95% CI 0.78–0.80), the rest of the scores presented lower discrimination ability (P<0.001): CHAD2DS2-VASc AUC 0.76, POAF 0.71 and HATCH 0.70. The HL test showed a p>0.05. For the new score, the best cut-off point was 2, with a sensitivity of 82% and specificity of 65.9%, presenting high negative predictive value: 92.9%. Variables OR (CI 95%) P Age (years) 65–74 3.14 (2.29–4.31) <0.001 ≥75 8.68 (6.32–11.93) <0.001 Female sex 3.36 (2.68–4.22) <0.001 Heart failure 2.45 (1.82–3.31) <0.001 Stroke/TIA 2.33 (1.45–3.76) <0.001 Hypertension 1.68 (1.28–2.2) <0.001 Diabetes 1.72 (1.31–2.25) <0.001 Conclusion From the combination of variables with higher predictive value included in the POAF, CHA2DS2-VASc, and HATCH scores, a new risk system was created to predict AFCS, presenting a greater predictive ability than the original ones. Being necessary future prospective validations. |
Author | Seoane, L Espinoza, J C Berton, F Baro Vila, R Villalba, L Furmento, J F Polero, L D Burgos, L M Gil Ramirez, A Benzadon, M N Cracco, M A Navia, D Miranda, P R |
Author_xml | – sequence: 1 givenname: L M surname: Burgos fullname: Burgos, L M organization: Cardiovascular Institute of Buenos Aires (ICBA), Buenos Aires, Argentina – sequence: 2 givenname: A surname: Gil Ramirez fullname: Gil Ramirez, A organization: Cardiovascular Institute of Buenos Aires (ICBA), Buenos Aires, Argentina – sequence: 3 givenname: J C surname: Espinoza fullname: Espinoza, J C organization: Cardiovascular Institute of Buenos Aires (ICBA), Buenos Aires, Argentina – sequence: 4 givenname: L surname: Seoane fullname: Seoane, L organization: Cardiovascular Institute of Buenos Aires (ICBA), Buenos Aires, Argentina – sequence: 5 givenname: J F surname: Furmento fullname: Furmento, J F organization: Cardiovascular Institute of Buenos Aires (ICBA), Buenos Aires, Argentina – sequence: 6 givenname: P R surname: Miranda fullname: Miranda, P R organization: Cardiovascular Institute of Buenos Aires (ICBA), Buenos Aires, Argentina – sequence: 7 givenname: L surname: Villalba fullname: Villalba, L organization: Cardiovascular Institute of Buenos Aires (ICBA), Buenos Aires, Argentina – sequence: 8 givenname: M A surname: Cracco fullname: Cracco, M A organization: Cardiovascular Institute of Buenos Aires (ICBA), Buenos Aires, Argentina – sequence: 9 givenname: L D surname: Polero fullname: Polero, L D organization: Cardiovascular Institute of Buenos Aires (ICBA), Buenos Aires, Argentina – sequence: 10 givenname: R surname: Baro Vila fullname: Baro Vila, R organization: Cardiovascular Institute of Buenos Aires (ICBA), Buenos Aires, Argentina – sequence: 11 givenname: F surname: Berton fullname: Berton, F organization: Cardiovascular Institute of Buenos Aires (ICBA), Buenos Aires, Argentina – sequence: 12 givenname: D surname: Navia fullname: Navia, D organization: Cardiovascular Institute of Buenos Aires (ICBA), Buenos Aires, Argentina – sequence: 13 givenname: M N surname: Benzadon fullname: Benzadon, M N organization: Cardiovascular Institute of Buenos Aires (ICBA), Buenos Aires, Argentina |
BookMark | eNqNkNtqwkAURYdioWr7CYX5geiczCWTxyK9gfQCPvQtTOZSx8ZEzkSK_Xojlj4XDmw4sDabNSGjtms9IbfAZsBKPvd7XHuD_Wbu1z-FkDMAEBdkDDLPs1IJOSJjBqXMlNIfV2SS0oYxphWoMXl_EwXXL_6b2m5bx9Y7ijF90WQ79LTv6A69i7anpsdoGhpijbFpTB-7lprQe6TWoIvG0rTHT4-Ha3IZTJP8zW9OyerhfrV4ypavj8-Lu2VmdSEyHnJeQzmcA6shaF5KIYxSkikXIHcql7njUNfDjzM3rBXaWAclOJsXgU-JPNda7FJCH6odxq3BQwWsOmmp_rRUZy3VScvAsTPX7Xf_RI5TcGxP |
ContentType | Journal Article |
Copyright | Published on behalf of the European Society of Cardiology. All rights reserved. © The Author(s) 2019. For permissions, please email: journals.permissions@oup.com. 2019 |
Copyright_xml | – notice: Published on behalf of the European Society of Cardiology. All rights reserved. © The Author(s) 2019. For permissions, please email: journals.permissions@oup.com. 2019 |
DBID | AAYXX CITATION |
DOI | 10.1093/eurheartj/ehz745.1114 |
DatabaseName | CrossRef |
DatabaseTitle | CrossRef |
DatabaseTitleList | CrossRef |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
DocumentTitleAlternate | ESC Congress 2019 together with World Congress of Cardiology 31 August – 4 September 2019, Paris - France |
EISSN | 1522-9645 |
ExternalDocumentID | 10_1093_eurheartj_ehz745_1114 10.1093/eurheartj/ehz745.1114 |
GroupedDBID | --- -E4 .2P .I3 .XZ .ZR 08P 0R~ 18M 1TH 29G 2WC 4.4 482 48X 53G 5GY 5RE 5VS 5WA 5WD 70D AABZA AACZT AAJKP AAMVS AAOGV AAPNW AAPQZ AAPXW AARHZ AASNB AAUAY AAUQX AAVAP ABEUO ABIXL ABKDP ABNHQ ABNKS ABOCM ABPTD ABQLI ABQNK ABWST ABXVV ABZBJ ACGFO ACGFS ACPRK ACUFI ACUTJ ACUTO ACYHN ADBBV ADEYI ADEZT ADGZP ADHKW ADHZD ADIPN ADJQC ADOCK ADQBN ADRIX ADRTK ADVEK ADYVW ADZXQ AEGPL AEGXH AEJOX AEKSI AEMDU AENEX AENZO AEPUE AETBJ AEWNT AFFZL AFIYH AFOFC AFXAL AFXEN AGINJ AGKEF AGQXC AGSYK AGUTN AHMBA AHXPO AIAGR AIJHB AJEEA ALMA_UNASSIGNED_HOLDINGS ALUQC APIBT APWMN ATGXG AXUDD BAWUL BAYMD BCGUY BCRHZ BEYMZ BHONS BTRTY BVRKM C45 CDBKE CS3 CZ4 DAKXR DIK DILTD D~K E3Z EBS EE~ EJD EMOBN ENERS F5P F9B FECEO FLUFQ FOEOM FOTVD FQBLK GAUVT GJXCC GX1 H13 H5~ HAR HW0 HZ~ IOX J21 KAQDR KBUDW KOP KQ8 KSI KSN L7B M-Z M41 M49 MHKGH ML0 N9A NGC NOMLY NOYVH NU- O9- OAUYM OAWHX OB3 OCZFY ODMLO OGROG OJQWA OJZSN OK1 OPAEJ OVD OWPYF P2P PAFKI PEELM PQQKQ Q1. Q5Y R44 RD5 ROL ROX ROZ RUSNO RW1 RXO SEL TCURE TEORI TJX W8F WOQ X7H YAYTL YKOAZ YXANX ZKX ~91 AAYXX CITATION |
ID | FETCH-LOGICAL-c874-3f23b19b19d1c81f839544a66506df12d6252d31bba6630d86148acd191dc27f3 |
ISSN | 0195-668X |
IngestDate | Thu Sep 12 18:57:11 EDT 2024 Wed Sep 11 04:51:50 EDT 2024 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | Supplement_1 |
Keywords | Cardiovascular Surgery - Arrhythmias |
Language | English |
License | This article is published and distributed under the terms of the Oxford University Press, Standard Journals Publication Model (https://academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model) |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c874-3f23b19b19d1c81f839544a66506df12d6252d31bba6630d86148acd191dc27f3 |
ParticipantIDs | crossref_primary_10_1093_eurheartj_ehz745_1114 oup_primary_10_1093_eurheartj_ehz745_1114 |
PublicationCentury | 2000 |
PublicationDate | 20191001 2019-10-01 |
PublicationDateYYYYMMDD | 2019-10-01 |
PublicationDate_xml | – month: 10 year: 2019 text: 20191001 day: 01 |
PublicationDecade | 2010 |
PublicationTitle | European heart journal |
PublicationYear | 2019 |
Publisher | Oxford University Press |
Publisher_xml | – name: Oxford University Press |
SSID | ssj0008616 |
Score | 2.348281 |
Snippet | Abstract
Introduction
Atrial fibrillation after cardiac surgery (AFCS) is associated with an increase in adverse events. The scores POAF, CHA2DS2-VASc and... |
SourceID | crossref oup |
SourceType | Aggregation Database Publisher |
Title | P4738New combined risk score to predict atrial fibrillation after cardiac surgery |
Volume | 40 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3dSxtBEF-qBfGl1FbRqmUf-iLhonu79_UoJUaKKSop5O2429vViCYhOV_y1zuzu_eRGooWwnEsYbi7-TE7M_ubGUJ-aImTT7LEEzI-80QktZdpVnia8wiPcVSYYUJ_8Du8_CN-jYJRc1xgqkvKvCuXa-tK_kersAZ6xSrZd2i2FgoLcA_6hStoGK5v0vG1iLiZpQPCIcJVjim-wNaU6FTO5ngMgwWLZjaHRnr_oyW_ueHg0gBEdhavq6PrPD3OvC477Qey5Q93lqF31SRU--PHzm32BFZ0uZIm7S1m48l0aWm5rbysmjqm7VU7-cCSmsZW5yOTwAtDMx0YthNnQyG-TULbJbIysrYnkwOTGVhqsp8pW2vGbYsr9Tw3b_iA9_fLSARo4EWzc1Wn9X9taDXN0B6w87QWlFoxGPaIDfLRB-OENMD-qKEFxaEZl1u_WFX1lfDTWsxp62lW_BmskWy5J8PP5JOLK-i5BckO-aAmX8jWwDEnvpKbCiu0wgpFrFCDFVpOqcMKtVihbaxQgxXqsEIdVnbJ8KI3_HnpuXEanowj4XHt85wl8CuYjJkGzzgQIgvBRQ8LzfwCImG_4CzPYY2fFTG2iM1kAQF9If1I8z2yOZlO1D6hOK46kj6EokwKkcdZkCdBHPmKsSQWmTog3eqbpDPbNCX9py4OyAl8ubf999t7hR-S7Qa6R2SznD-rY_Aky_y7Uf0LJoZ2Hw |
link.rule.ids | 315,783,787,27938,27939 |
linkProvider | Geneva Foundation for Medical Education and Research |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=P4738New+combined+risk+score+to+predict+atrial+fibrillation+after+cardiac+surgery&rft.jtitle=European+heart+journal&rft.au=Burgos%2C+L+M&rft.au=Gil+Ramirez%2C+A&rft.au=Espinoza%2C+J+C&rft.au=Seoane%2C+L&rft.date=2019-10-01&rft.issn=0195-668X&rft.eissn=1522-9645&rft.volume=40&rft.issue=Supplement_1&rft_id=info:doi/10.1093%2Feurheartj%2Fehz745.1114&rft.externalDBID=n%2Fa&rft.externalDocID=10_1093_eurheartj_ehz745_1114 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0195-668X&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0195-668X&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0195-668X&client=summon |